Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > Nice little pump for insiders

<< Previous

Bullboard Posts

Next >>

Comment by Padinaon Dec 03, 2020 9:57am

32 Views

Post# 32025362

RE:Nice little pump for insiders

SEDA fillings does not support the notion that insiders sold shares rather what we have is insiders buying. Penny flippers ar responsible for the price drop.
Insiders are not selling, if retail holders too can ear d temporary pain for future great gain, the stock will do well at retaining its gain.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China